SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-033923
Filing Date
2024-03-13
Accepted
2024-03-13 16:07:08
Documents
17
Period of Report
2024-03-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm248691d1_8k.htm   iXBRL 8-K 31310
2 EXHIBIT 1.1 tm248691d1_ex1-1.htm EX-1.1 271678
3 EXHIBIT 5.1 tm248691d1_ex5-1.htm EX-5.1 8977
7 GRAPHIC tm248691_ex5-1img002.jpg GRAPHIC 6121
  Complete submission text file 0001104659-24-033923.txt   564295

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cgtx-20240311.xsd EX-101.SCH 3006
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgtx-20240311_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgtx-20240311_pre.xml EX-101.PRE 22353
18 EXTRACTED XBRL INSTANCE DOCUMENT tm248691d1_8k_htm.xml XML 3620
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40886 | Film No.: 24745965
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)